CRISPR/Cas Technology, Innovation and Regulation

In the field of precision genome editing, CRISPR/Cas technology stands out for its specificity and efficiency in modifying DNA sequences. Given its characteristics as a general-purpose technology, CRISPR/Cas applications hold the potential to bring about significant social benefits across sectors. Building on earlier exploratory work, the Institute has deepened its study of interactions between CRISPR/Cas technology and the intellectual property (IP) framework, focusing on the agricultural sector in view of the potential of CRISPR/Cas technology to enhance global food security and address the impacts of climate change. Furthermore, it has taken a close look at the field of marketing authorization regulation for CRISPR/Cas and its implications for innovation and technology diffusion. The overarching research question is how the existing regulatory framework can be improved to facilitate the realization of the social benefits of precision genome editing.